CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net income (loss)	$ (22,031)	$ 77,291
Adjustments to net income (loss):
Depreciation and amortization	317,826	322,729
Deferred income tax expense (benefit)	11,239	12,135
Impairments and other charges		5,318
Amortization of debt discount and deferred financing costs	4,527	4,239
Losses (gains) on debt buyback	2,576	(25,098)
Losses (gains) on long-lived assets, net	11,111	927
Losses (gains) on investments, net	414	(960)
Share-based compensation	7,732	8,321
Foreign currency transaction losses (gains), net	17,894	16,810
Mark-to-market (gain) loss on warrants	(9,594)	(52,466)
Other	2,576	98
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(20,044)	27,461
Inventory	(1,574)	(24,125)
Other current assets	(8,023)	(5,595)
Other long-term assets	57	(6,373)
Trade accounts payable and accrued liabilities	887	(44,506)
Income taxes payable	(12,893)	1,896
Other long-term liabilities	(13,782)	4,414
Net cash provided by (used for) operating activities	288,898	322,516
Cash flows from investing activities:
Purchases of investments	(7,625)	(24,551)
Capital expenditures	(231,995)	(263,485)
Proceeds from sales of assets	7,860	5,050
Other	4,662	12
Net cash (used for) provided by investing activities	(227,098)	(282,974)
Cash flows from financing activities:
Proceeds from issuance of long-term debt		250,000
Reduction in long-term debt	(631,043)	(292,853)
Debt issuance costs	(1,343)	(8,036)
Proceeds from revolving credit facilities	130,000	125,000
Reduction in revolving credit facilities	(130,000)	(125,000)
Payments for employee taxes on net settlement of equity awards	(2,634)	(7,079)
Dividends to common and preferred shareholders	(87)	(194)
Distributions to noncontrolling interest	(950)	(2,269)
Special purpose acquisition company redemptions by non-controlling redeemable shareholders		(186,933)
Other	(282)
Net cash (used for) provided by financing activities	(636,339)	(247,364)
Effect of exchange rate changes on cash and cash equivalents	(9,197)	(8,641)
Net increase (decrease) in cash and cash equivalents and restricted cash	(583,736)	(216,463)
Cash and cash equivalents and restricted cash, beginning of period	1,374,182	737,140
Cash and cash equivalents and restricted cash, end of period	790,446	520,677
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	1,057,487	451,025
Restricted cash, beginning of period	316,695	286,115
Cash and cash equivalents and restricted cash, beginning of period	1,374,182	737,140
Cash and cash equivalents, end of period	465,953	413,376
Restricted cash, end of period	$ 324,493	$ 107,301
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 790,446	$ 520,677